Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2007 Jun;117(6):1483-5.
doi: 10.1172/JCI32356.

A beneficial role for IL-1 beta in Alzheimer disease?

Affiliations
Comment

A beneficial role for IL-1 beta in Alzheimer disease?

Cynthia A Lemere. J Clin Invest. 2007 Jun.

Abstract

While the term neuroinflammation often conjures up images of cellular damage, mounting evidence suggests that certain proinflammatory molecules, such as the cytokine IL-1 beta, may have beneficial and protective effects. In a report in this issue of the JCI, Shaftel and coworkers have generated an elegant mouse model in which local hippocampal overexpression of IL-1 beta in an Alzheimer disease (AD) transgenic mouse model resulted not in the expected exacerbation of the amyloid beta plaque deposition common to AD, but instead in plaque amelioration (see the related article beginning on page 1595). Thus, manipulation of the immune system may be a potential therapeutic approach to protect against AD, although further studies are needed to understand all of the downstream effects of this manipulation.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Overexpression of IL-1β activates glial cells and reduces Aβ plaque deposition in a mouse model of AD.
In this issue of the JCI, Shaftel and colleagues (5) used XAT technology to generate IL-1βXAT transgenic mice and crossbred these mice with APP/PS1 mice, a mouse model used to study AD. Intrahippocampal injection of FIV-Cre at 6 months of age locally activated the IL-1β transgene and increased the levels of IL-1β and glial fibrillary acid protein (GFAP), indicative of astrocytic activation, as well as Iba-1 and MHC class II, indicative of microglial activation. One month later, instead of observing a worsening of AD-like pathogenesis as expected, the authors found that IL-1β overexpression in the APP/PS1+IL-1β mouse resulted in reduced Aβ plaque deposition and lower insoluble Aβ levels in the injected ipsilateral hippocampus compared with the control-injected contralateral hippocampus. Levels of APP and β-secretase, one of the APP-cleaving enzymes responsible for generating Aβ, were unchanged, suggesting that Aβ production was not affected. Instead, IL-1β overexpression led to increased microglial activation and possibly, as the authors hypothesize, clearance of Aβ deposits by microglial phagocytosis. CA, cornu ammonis; DG, dentate gyrus.

Comment on

References

    1. Morgan D., Gordon M.N., Tan J., Wilcock D., Rojiani A.M. Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer’s therapeutics. J. Neuropathol. Exp. Neurol. 2005;64:743–753. - PubMed
    1. Eikelenboom P., et al. The significance of neuroinflammation in understanding Alzheimer’s disease. J. Neural Transm. 2006;113:1685–1695. - PubMed
    1. Wyss-Coray T. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 2006;12:1005–1015. - PubMed
    1. Wolfe M. Shutting down Alzheimer’s. Sci. Am. 2006;294:72–79. - PubMed
    1. Shaftel S.S., et al. Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J. Clin. Invest. 2007;117:1595–1604. doi: 10.1172/JCI31450. - DOI - PMC - PubMed